Regulation of In Vitro Immunocyte Activation

Supernatants from incubated normal mouse spleen cells suppressed the DNA synthetic response induced by polyclonal B‐ and T‐cell activators and the primary immune response to sheep erythrocytes in normal spleen cells in vitro. The inhibitory effects of the supernatants were found to be dependent on the culture system used. The main cell population producing or releasing the inhibitory factors was nonadherent spleen cells, but macrophages and bone marrow cells could also give supernatants with inhibitory effects. Thymocytes did nut release any inhibitors under the same conditions. Separation of the supernatants showed that there were it least two factors with inhibitory effects on proliferation in lymphocytes. One of these factors had a molecular weight of less than 10,000 (not degradable by protease) and suppressed activation by all tested polyclonal B‐ and T‐cell activators. Another factor (a protein with a molecular weight of more than 30, 000) inhibited activation by some polyclonal B‐cell activators (lipopolysaccharide, type III pneumococcal polysaccharide) whereas the proliferation induced by dextran sulfate Was less or not at all affected under the same culture conditions. Trivial mechanisms for inhibition by supernatant factors, such as medium depletion, general toxicity, and accumulation of free thymidine in the medium, were excluded.

[1]  A. Coutinho,et al.  Heterogeneity of B Cells: Direct Evidence of Selective Triggering of Distinct Subpopulations by Polyclonal Activators , 1976, Scandinavian Journal of Immunology.

[2]  A. Coutinho,et al.  Responsiveness of Lymphoid Precursors to Polyclonal B‐Cell Activators , 1975, Scandinavian journal of immunology.

[3]  R. Jackson,et al.  Biochemical characterization of a factor released by macrophages. , 1975, Cellular immunology.

[4]  E. Unanue,et al.  An inhibitor of cell proliferation released by cultures of macrophages. , 1974, Proceedings of the National Academy of Sciences of the United States of America.

[5]  A. Coutinho,et al.  Selective triggering of B cell subpopulations by mitogens , 1974, European journal of immunology.

[6]  A. Coitinho,et al.  Differentiation of B Cells: Sequential Appearance of Responsiveness to Polyclonal Activators , 1974, Scandinavian journal of immunology.

[7]  A. Coutinho,et al.  Immune Activation of B Cells: Evidence for‘One Nonspecific Triggering Signal' Not Delivered by the Ig Receptors , 1974, Bollettino dell'Istituto sieroterapico milanese.

[8]  E. Hersh,et al.  MECHANISM OF PRODUCTION OF INHIBITOR OF LYMPHOCYTE BLASTOGENIC RESPONSE TO MITOGENS BY CULTURED LYMPHOBLASTOID CELL LINE CELLS , 1974, Transplantation.

[9]  D. Nelson,et al.  Effect of normal mouse serum on mouse lymphocyte transformation in vitro , 1974, European journal of immunology.

[10]  A. Coutinho,et al.  MECHANISM OF THYMUS-INDEPENDENT IMMUNOCYTE TRIGGERING , 1974, The Journal of experimental medicine.

[11]  D. Nelson Production by Stimulated Macrophages of Factors depressing Lymphocyte Transformation , 1973, Nature.

[12]  A. Badger,et al.  Sensitivity of non-human cells to human lymphocyte 'proliferation inhibitory factor' (PIF) in vitro. , 1973, Clinical and experimental immunology.

[13]  M. Cohn,et al.  THE USE OF BACTERIAL LIPOPOLYSACCHARIDES TO SHOW THAT TWO SIGNALS ARE REQUIRED FOR THE INDUCTION OF ANTIBODY SYNTHESIS , 1973, The Journal of experimental medicine.

[14]  R. Holzman,et al.  Preparation and properties of cloning inhibitory factor. I. Inhibition of HeLa cell cloning by stimulated lymphocytes and their culture supernatants. , 1973, Cellular immunology.

[15]  R. Holzman,et al.  Preparation and properties of cloning inhibitory factor. II. Factors affecting its production and assay. , 1973, Cellular immunology.

[16]  B. S. Nilsson,et al.  PPD tuberculin--a B-cell mitogen. , 1972, Nature: New biology.

[17]  E. Möller,et al.  “Spontaneous” B cell activation due to loss of normal mouse serum suppressor , 1972, European journal of immunology.

[18]  S. Britton Mouse Spleen Cells Cultivated in Homologous Serum Can Make Primary Antibodies in Vitro Provided the T‐Cells Are Non‐Specifically Activated , 1972, Scandinavian journal of immunology.

[19]  J. G. Michael,et al.  Immune response suppression by an inhibitor in normal and immune mouse serum. , 1972, Nature: New biology.

[20]  A. Badger,et al.  Direct observations on the effect of "proliferation inhibitory factor" on the clonal growth of target cells. , 1971, Journal of immunology.

[21]  W. Adler,et al.  Studies of an inhibitor of DNA synthesis and a nonspecific mitogen elaborated by human lymphoblasts. , 1970, The American journal of pathology.

[22]  S. Cooperband,et al.  Inhibition of target cell proliferation by supernatants from cultures of human peripheral lymphocytes. , 1970, Journal of immunology.

[23]  O. Mäkelä,et al.  Effect of the number of haptens coupled to each erythrocyte on haemolytic plaque formation. , 1969, Immunology.

[24]  G. Granger,et al.  Lymphocyte in vitro cytotoxicity: characterization of human lymphotoxin. , 1968, Proceedings of the National Academy of Sciences of the United States of America.

[25]  C. Zukoski,et al.  Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. , 1968, Clinical and experimental immunology.

[26]  R. Dutton,et al.  IMMUNIZATION OF DISSOCIATED SPLEEN CELL CULTURES FROM NORMAL MICE , 1967, The Journal of experimental medicine.

[27]  N. K. Jerne,et al.  Plaque Formation in Agar by Single Antibody-Producing Cells , 1963, Science.